← Eichor
Condition: Cerebral Revascularization Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Cerebral Revascularization

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Revascularization Effect on CSVD Burden in Carotid Artery Stenosis
Phase N/A · 1 location(s) · Zhejiang Provincial People's Hospital · NCT06031610
Selective Coronary Revascularization in Carotid Artery Disease Patients After Carotid Revascularization (SCORECAD Trial)
Phase N/A · 1 location(s) · Pauls Stradins Clinical University Hospital · NCT06546761
SVS VQI TransCarotid Revascularization Surveillance Project
Phase N/A · 1 location(s) · Society for Vascular Surgery Patient Safety Organization · NCT02850588
Neurovascular Product Surveillance Registry
Phase N/A · 99 location(s) · Medtronic Neurovascular Clinical Affairs · NCT02988128
Prediction of Cerebral Hyperperfusion Syndrome After Carotid Revascularization Using Deep Learning
Phase N/A · 1 location(s) · State Institution "Republican Scientific and Practical Cente · NCT05800821
Investigation of Brain Blood Flow Changes in Acute Ischemic Stroke Patients After Successful Endovascular Thrombectomy
Phase N/A · 1 location(s) · University of Zurich · NCT07534319
A Study Assessing Repatha® in Combination With Standard of Care (SOC) Compared With SOC on Major Cardiovascular Events i
Phase N/A · 90 location(s) · Amgen · NCT06295679
Lyon Registry of Stroke Treated by Thrombolysis or Thrombectomy
Phase N/A · 1 location(s) · Hospices Civils de Lyon · NCT04620642
3D Contrast Enhanced Microvascular Ultrasound of Carotid Atherosclerosis for the Detection of Carotid Plaque Neo-Revascu
NA · 1 location(s) · London North West Healthcare NHS Trust · NCT07298655
Study on the Trans-Carotid Artery Occlusion Shunt System
NA · 1 location(s) · Shenzhen Wecan Medical Technology Co.,Ltd · NCT06924593
Efficacy and Safety Study of Ultra-early Mobile Stroke Unit Neuroprotection Combined With Revascularization for Acute Is
Phase 4 · 1 location(s) · Ruijun Ji · NCT07119021
Change of Hemodynamics and Cerebral Functions After Carotid Artery Revascularization
Phase N/A · 1 location(s) · Beijing Friendship Hospital · NCT05539781
Safety and Efficacy of RIC in Pediatric Moyamoya Disease Patients Treated With Revascularization Therapy
NA · 1 location(s) · Capital Medical University · NCT03546309
VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb Revascularization
Phase 4 · 1 location(s) · Science Valley Research Institute · NCT06873321
EmboTrap ® II Revascularization Device (Neuravi) in Acute Ischemic Stroke
Phase N/A · 1 location(s) · Niguarda Hospital · NCT03601702
A Single-arm, Pivotal Study to Evaluate Acute Device and Technical Success of the CGuard Prime Carotid Stent System When
NA · 8 location(s) · InspireMD · NCT06653387
Simultaneous Cardiac Surgery and Micronet-covered Stent Carotid Revascularization in High Perioperative Stroke Risk Pati
Phase N/A · 1 location(s) · John Paul II Hospital, Krakow · NCT04973579
Clinical Impact of Using IMPROVE to Select Patients for Carotid Revascularisation
NA · 10 location(s) · Maastricht University Medical Center · NCT07556887
Early Neurovascular Decoupling Trajectories After Revascularization in Acute Ischemic Stroke
Phase N/A · 2 location(s) · Xijing Hospital · NCT07405762
The Evolution and Prognosis of Moyamoya Disease
Phase N/A · 1 location(s) · Chinese PLA General Hospital · NCT05619068
Mini-Crush Or Controlled Balloon-Crush For True Coronary Bifurcation Lesions
Phase N/A · 1 location(s) · Istanbul Mehmet Akif Ersoy Educational and Training Hospital · NCT06880978
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.